All 12 patients in study (100%) achieved insulin independence, producing their own insulin and no longer requiring exogenous insulin therapy to ...
("Eledon") (NASDAQ: ELDN) today announced updated results from an investigator-initiated trial evaluating tegoprubart, its investigational anti-CD40L antibody, as part of a calcineurin inhibitor-free ...
AERE warns banks’ N91.1tn CBN deposits are starving businesses of credit and worsening Nigeria’s fiscal vulnerabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results